Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antibe Therapeutics Inc

+ Add to Watchlist

ATE:CN

0.1950 CAD 0.0250 11.36%

As of 15:59:29 ET on 04/24/2015.

Snapshot for Antibe Therapeutics Inc (ATE)

Open: 0.2200 Day's Range: 0.1900 - 0.2200 Volume: 295,790
Previous Close: 0.2200 52wk Range: 0.0400 - 0.6500 1-Yr Rtn: -66.38%

Stock Chart for ATE

No chart data available.
  • ATE:CN 0.1950
  • 1D
  • 1M
  • 1Y
0.2200
Interactive ATE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.1200
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 8.75
Shares Outstanding (M) 44.87
30 Day Average Volume 596,679
Price/Book (mrq) 7.6435
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATE

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ATE

Antibe Therapeutics Inc designs and develops new pharmaceuticals. The Company focuses on diseases characterized by inflammation, pain and/or vascular dysfunction.

Walter M Macnee "Walt"ChairmanDaniel Legault "Dan"Chief Executive Officer
Michael BumbyChief Financial OfficerJohn L WallaceChief Scientific Officer/Founder
More Company Profile & Key Executives for ATE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil